Santa Cruz Biotechnology

Rad51 (H-92)

#sc-8349 · western blot

116
Citing papers
5.2k
Combined citations
Supplier page Find this product

Research areas

DNA Repair Mechanisms40PARP inhibition in cancer therapy23CRISPR and Genetic Engineering14Microtubule and mitosis dynamics7Cancer-related Molecular Pathways7Genomics and Chromatin Dynamics7Epigenetics and DNA Methylation6Cancer therapeutics and mechanisms3

Papers citing this product

1
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Nature·2018·415 cit.·DOI
2
Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double‐strand breaks
The EMBO Journal·2006·275 cit.·DOI
3
Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway
Molecular and Cellular Biology·2012·208 cit.·DOI
4
A short G1 phase imposes constitutive replication stress and fork remodelling in mouse embryonic stem cells
Nature Communications·2016·198 cit.·DOI
5
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery
Nature Communications·2016·183 cit.·DOI
6
Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
Nature Medicine·2015·161 cit.·DOI
7
Removal of H2A.Z by INO80 promotes homologous recombination
EMBO Reports·2015·145 cit.·DOI
8
Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly
Nature Communications·2020·138 cit.·DOI
9
PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
Oncogene·2017·133 cit.·DOI
10
Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
PLoS ONE·2012·116 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.